Treat-to-Target Study of Olmesartan Medoxomil and an Add-on Treatment Algorithm Consisting of Hydrochlorothiazide and Amlodipine Besylate in Patients With Mild to Moderate Hypertension
Treat-to-Target Study of Olmesartan Medoxomil and an Add-on Treatment Algorithm Consisting of Hydrochlorothiazide and Amlodipine Besylate in Patients With Mild to Moderate Hypertension
This study is to assess the safety and efficacy of an add-on treatment algorithm with olmesartan, hydrochlorothiazide and amlodipine in patients with mild to moderate hypertension.
Inclusion Criteria:
Exclusion Criteria:
Salzburg-Aigen, 5026, Austria
Seraing, 4100, Belgium
Mühldorf / Inn, 84453, Germany
VS-Villingen, 78050, Germany
Elvas, 7350-954, Netherlands
Almada Almada, 2801-951, Portugal
Amadora Amadora, 2720-276, Portugal
Lisboa Lisboa, 1169-024, Portugal